NewAmsterdam Pharma Company N.V. Ordinary Shares (NYSE: NAMS) — Healthcare · Share Price, Chart & Market Data
About: NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $30.19 (+1.58%)
NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
Loading watchlist status…
Trade NAMS now
NewAmsterdam Pharma Company N.V. Ordinary Shares share price
NAMS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:34 pm GMT+0
NAMS price performance
-7.05%
5D
0.7%
1M
-14.233%
YTD
69.321%
1Y
NAMS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:34 pm GMT+0
NAMS details
NAMS Market Signals